PHYSICIAN AND PATIENT PERCEPTIONS REGARDING CARE TRANSITIONS, ORAL ANTICOAGULANT TREATMENT AND MANAGEMENT OF NON-VALVULAR ATRIAL FIBRILLATION

被引：0
|
作者：
Stephenson, J. [1 ]
Franchino-Elder, J. [2 ]
Zhang, X. [1 ]
Tan, H. [3 ]
Kraft, E. [4 ]
Wang, C. [2 ]
Willey, V [1 ]
机构：
[1] HealthCore Inc, Wilmington, DE USA
[2] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[3] HealthCore Inc, San Diego, CA USA
[4] Anthem, Denver, CO USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.520
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV84
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [31] Effectiveness and safety of oral anticoagulation treatment with acenocoumarol in non-valvular atrial fibrillation
    Castro, Constanza
    Bustos, Luis
    Ocampo, Renato
    Molina, Elda
    Cabrero, Pia
    Vergara, Rene
    Lanas, Fernando
    REVISTA MEDICA DE CHILE, 2017, 145 (10) : 1243 - 1251
  • [32] Long-term oral anticoagulant management associated with routine medical care (RMC) in patients with non-valvular atrial fibrillation (NVAF) in Canada
    Selby, R.
    Mittmann, N.
    Isogai, P.
    Kaus, L.
    Koo, M.
    Sealey, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 688 - 688
  • [33] Long-Term Oral Anticoagulant Management Associated with Routine Medical Care (RMC) In Patients with Non-Valvular Atrial Fibrillation (NVAF) In Canada
    Selby, Rita
    Mittmann, Nicole
    Isogai, Pierre K.
    Kaus, Lisa
    Koo, Marika
    Sealey, Faith
    BLOOD, 2011, 118 (21) : 1793 - 1793
  • [34] Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study
    Özcan Başaran
    Volkan Dogan
    Osman Beton
    Mehmet Tekinalp
    Ahmet Çağrı Aykan
    Ezgi Kalaycıoğlu
    Ismail Bolat
    Onur Taşar
    Özgen Şafak
    Macit Kalçık
    Mehmet Yaman
    Sinan İnci
    Bernas Altıntaş
    Sedat Kalkan
    Cevat Kırma
    Murat Biteker
    Journal of Thrombosis and Thrombolysis, 2017, 43 : 157 - 165
  • [35] Ischaemic stroke in a patient with non-valvular atrial fibrillation (NVAF) despite non-vitamin K oral anticoagulant (NOAC) therapy
    Zhen, Simon
    Chu, Fion
    Kodesh, Afek
    Kim, Jisoon
    BMJ CASE REPORTS, 2024, 17 (01)
  • [36] Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study
    Basaran, Ozcan
    Dogan, Volkan
    Beton, Osman
    Tekinalp, Mehmet
    Aykan, Ahmet Cagri
    Kalaycioglu, Ezgi
    Bolat, Ismail
    Tasar, Onur
    Safak, Ozgen
    Kalcik, Macit
    Yaman, Mehmet
    Inci, Sinan
    Altintas, Bernas
    Kalkan, Sedat
    Kirma, Cevat
    Biteker, Murat
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (02) : 157 - 165
  • [37] Prevalence of Valvular and Non-valvular Atrial Fibrillation and the Application of Antithrombotic Treatment in a Tertiary Care Hospital
    Dhungana, Sahadeb Prasad
    Ghimire, Rinku
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2020, 58 (231) : 851 - 855
  • [38] Giant left atrial thrombus in a patient with non-valvular atrial fibrillation
    Wang, Yao
    Liang, Yan
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2024, 8 (11)
  • [39] PRICE ELASTICITY OF DEMAND FOR NEW ORAL ANTICOAGULANT AGENTS AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Liu, S.
    Jackson, J.
    Khalaf, K.
    Meyer, K. L.
    Brown, D.
    VALUE IN HEALTH, 2016, 19 (03) : A49 - A49
  • [40] Modern approaches to anticoagulant therapy during catheter ablation treatment of non-valvular atrial fibrillation
    Belikov, E. A.
    Davtyan, K. V.
    Tkacheva, O. N.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2014, 10 (04) : 432 - 437
12345